http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-105686-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2573d77d1c30178714a2aac67fb225d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 |
filingDate | 2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a62a1ff2e7524b53cc1c47e3de15f3f |
publicationDate | 2017-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-105686-A1 |
titleOfInvention | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALOPECÍA |
abstract | A composition for the treatment of alopecia containing minoxidil, cyclosporin A and a compound that binds to FK506 binding protein 4 suitable for administration to humans. Treatment of alopecia in humans by administration of a composition of the present. Claim 4: A composition for the treatment of alopecia comprising a compound of formula (1) or a pharmaceutically acceptable salt or an ester thereof, minoxidil and cyclosporine A, wherein R¹ is selected from the group consisting of COOH, methoxy, phenyl, benzyl, substituted phenyl and substituted benzyl. Claim 6: The composition of claim 4 wherein the compound of formula (1) is selected from the group consisting of the group compounds of formulas (2), and a pharmaceutically acceptable salt or ester thereof. |
priorityDate | 2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.